Improving Physical Activity in Patients With Severe Chronic Obstructive Pulmonary Disease With Urban Walking Circuits

Hospital de Mataró1 site in 1 country82 target enrollmentApril 2008

ConditionsSevere Chronic Obstructive Pulmonary Disease

Overview

Phase: N/A
Intervention: Not specified
Conditions: Severe Chronic Obstructive Pulmonary Disease
Sponsor: Hospital de Mataró
Enrollment: 82
Locations: 1
Primary Endpoint: walked in meters in the six minute walking test (6MWT)
Status: Completed
Last Updated: 12 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The aim of this study was to assess the effectiveness of the implementation of walking urban circuits in increasing the level of physical activity and exercise capacity in severe chronic obstructive pulmonary disease (COPD) patients after being enrolled in a pulmonary rehabilitation program.

Registry

clinicaltrials.gov

Start Date

April 2008

End Date

June 2011

Last Updated

12 years ago

Study Type

Interventional

Study Design

Parallel

Sex

Male

Investigators

Sponsor

Hospital de Mataró

Responsible Party

Principal Investigator

Eulogio Pleguezuelos

MD PhD

Hospital de Mataró

Eligibility Criteria

Inclusion Criteria

•severe COPD (post-bronchodilator Forced expiratory volume in one second (FEV1)/ Forced vital capacity (FVC) \<0.7 and FEV1 \<50%) and stable disease defined as no exacerbation, hospital admission or change in treatment in the previous three months.

Exclusion Criteria

•The exclusion criteria were: other significant respiratory disease (bronchiectasis, lung fibrosis, asthma, etc.), active smoking, severe cardiovascular, neurological, musculoskeletal and/or metabolic pathology that could interfere with the results, alcoholism (\>80g/day) or severe malnutrition (BMI\<19kg/m2).

Outcomes

Primary Outcomes

walked in meters in the six minute walking test (6MWT)

Time Frame: Unlike walking meters of baseline and one year

The 6MWT was standardized following international recommendations. Oxygen saturation and heart rate were recorded throughout the test using a pulsioximeter (Digit ® Finger Oximeter, Smiths Medical PM, USA). Dyspnea was evaluated using the modified Borg scale at the beginning and end of the test